Scarica l'app Stockscreener
320.38
1.55%
4.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Precedente Chiudi:
$315.49
Aprire:
$318.24
Volume 24 ore:
567.33K
Relative Volume:
0.91
Capitalizzazione di mercato:
$22.55B
Reddito:
$2.36B
Utile/perdita netta:
$236.10M
Rapporto P/E:
97.50
EPS:
3.286
Flusso di cassa netto:
$382.50M
1 W Prestazione:
+2.62%
1M Prestazione:
-9.19%
6M Prestazione:
+21.03%
1 anno Prestazione:
+38.19%
Intervallo 1D:
$315.83
$324.69
Intervallo di 1 settimana:
$306.02
$324.69
Portata 52W:
$226.50
$353.50
Insulet Corporation Stock (PODD) Company Profile
Nome
Insulet Corporation
Settore
Industria
Telefono
978-600-7000
Indirizzo
100 NAGOG PARK, ACTON, MA
Confronta PODD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
320.38 | 22.21B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
133.31 | 233.69B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.28 | 143.42B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.20 | 143.48B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.50 | 125.54B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.19 | 44.47B | 5.69B | 1.41B | 577.90M | 6.9828 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Ripresa | Oppenheimer | Outperform |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-05-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-07 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-08-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-07-28 | Iniziato | Wells Fargo | Overweight |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Iniziato | BofA/Merrill | Neutral |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-12-10 | Iniziato | CFRA | Sell |
| 2019-10-23 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-10-04 | Downgrade | UBS | Buy → Neutral |
| 2019-10-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-04-20 | Iniziato | Berenberg | Buy |
| 2018-02-22 | Reiterato | Barclays | Overweight |
| 2018-01-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Iniziato | Barclays | Overweight |
Mostra tutto
Insulet Corporation Borsa (PODD) Ultime notizie
Insulet to Host Investor Day on November 20, 2025 - Stock Titan
Blair William & Co. IL Sells 13,724 Shares of Insulet Corporation $PODD - MarketBeat
What RSI levels show for Insulet Corporation (GOV) stockLayoff News & Accurate Intraday Trading Signals - newser.com
Long term hold vs stop loss in Insulet CorporationWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Pattern recognition hints at Insulet Corporation upsideQuarterly Trade Report & Comprehensive Market Scan Insights - newser.com
Truist Securities Reiterates Buy Rating on Insulet (PODD) Stock - MSN
Forecasting Insulet Corporation price range with options dataJuly 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com
What MACD signals say about Insulet CorporationJuly 2025 WrapUp & Fast Gain Stock Tips - newser.com
Is now a turning point for Insulet CorporationJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com
Insulet (NASDAQ:PODD) Earns "Hold (C)" Rating from Weiss Ratings - MarketBeat
What Fibonacci levels say about Insulet Corporation rebound2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Insulet Opens Global Capability Center in Guadalajara - Mexico Business News
Insulet Corp. Experiences Evaluation Revision Amidst Mixed Market Dynamics and Strong Performance - Markets Mojo
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com
Insulet Corporation $PODD Shares Sold by SGL Investment Advisors Inc. - MarketBeat
Real time scanner hits for Insulet Corporation explainedRisk Management & Technical Pattern Alert System - newser.com
Highland Capital Management LLC Makes New Investment in Insulet Corporation $PODD - MarketBeat
Why analysts remain bullish on Insulet Corporation stockGold Moves & Long-Term Growth Portfolio Plans - newser.com
Insulet (PODD): A Fresh Look at Valuation Following Raised Guidance and Strong Q2 Growth - simplywall.st
How sentiment analysis helps forecast Insulet CorporationMarket Weekly Review & Fast Moving Market Watchlists - newser.com
Insulet Corporation $PODD Shares Acquired by ASR Vermogensbeheer N.V. - MarketBeat
What Analyst Watch Lists Suggest About Simplex Infrastructures Limiteds MomentumEarnings Revision Updates & Minimal Investment Trading Tips - earlytimes.in
Insulet (NASDAQ:PODD) Given New $370.00 Price Target at Rothschild & Co Redburn - MarketBeat
Franklin Street Advisors Inc. NC Makes New Investment in Insulet Corporation $PODD - MarketBeat
How Investors Are Reacting To Insulet (PODD) Raising Guidance After Surging Q2 Revenue and New Product Launch - simplywall.st
Rothschild & Co Redburn Adjusts Price Target on Insulet to $370 From $350, Maintains Buy Rating - MarketScreener
Can Omnipod Mango’s Bold Design Shift Signal a New Strategy for Insulet (PODD)? - simplywall.st
Lecap Asset Management Ltd. Takes Position in Insulet Corporation $PODD - MarketBeat
Robeco Institutional Asset Management B.V. Buys 119,786 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Purchased by Janney Montgomery Scott LLC - MarketBeat
Is Insulet Corporation (GOV) stock a buy for dividend portfoliosJuly 2025 Breakouts & Reliable Price Breakout Alerts - newser.com
Insulet Corporation stock retracement – recovery analysisEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Will Insulet Corporation (GOV) stock deliver stable dividendsForecast Cut & AI Based Buy and Sell Signals - newser.com
AMI Asset Management Corp Has $50.88 Million Stock Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Sold by USA Financial Formulas - MarketBeat
Lbp Am Sa Buys Shares of 15,629 Insulet Corporation $PODD - MarketBeat
Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating - Yahoo Finance
Healthcare Stocks With Consistent 10%+ Revenue Growth - TIKR.com
Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance - Yahoo Finance
Oversold Conditions For Insulet (PODD) - Nasdaq
Insulet (NASDAQ:PODD) Stock Price Down 3.4% Following Analyst Downgrade - MarketBeat
Chicago Capital LLC Has $55.92 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Canaccord Genuity raises Insulet stock price target to $399 on T2D advantage - Investing.com Nigeria
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Insulet (PODD) Sees Target Price Raised by Canaccord Genuity | P - GuruFocus
A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts - Benzinga
Canaccord Genuity Maintains Insulet (PODD) Buy Recommendation - Nasdaq
Insulet Corporation (PODD) PT Raised to $399 at Canaccord Genuity - StreetInsider
Insulet Corporation Azioni (PODD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):